HITIQ and Shock Doctor Unite for Global Concussion Management Breakthrough

HitIQ Limited ( (AU:HIQ) ) just unveiled an update.

HITIQ Limited has announced an exclusive global agreement with Shock Doctor, the leading global mouthguard brand, to integrate HITIQ’s PROTEQT technology into a self-fit ‘boil and bite’ mouthguard. This collaboration aims to revolutionize concussion management by combining HITIQ’s sensor technology with Shock Doctor’s design expertise, enabling global commercialization and setting a new standard for athlete safety. The partnership will facilitate the production of 20,000 units in 2025 and 100,000 units in 2026, with the product being rolled out to community sports through various partnerships. This agreement positions HITIQ as a leader in the athlete safety industry, supported by World Rugby’s approval and a U.S. patent for its Nexus technology.

More about HitIQ Limited

HITIQ Limited is a company specializing in concussion management technology. Its primary product, the PROTEQT instrumented mouthguard, integrates advanced sensor technology to detect head impacts and assess concussion risks. The company focuses on enhancing athlete safety through innovative solutions and strategic partnerships.

Average Trading Volume: 440,594

Technical Sentiment Signal: Sell

Current Market Cap: A$8.07M

Find detailed analytics on HIQ stock on TipRanks’ Stock Analysis page.